B06.01 Rubella encephalitis

Name of the Condition

• Rubella encephalitis

Summary

Rubella encephalitis is a rare neurological complication of rubella infection, characterized by inflammation of the brain. It occurs when the rubella virus invades the central nervous system, leading to acute neurological symptoms. This condition may develop during or after the acute phase of rubella, which typically presents with a rash and fever. Encephalitis is more common in individuals with congenital rubella or immunocompromised states, though it can occur in otherwise healthy people.

Causes

Rubella encephalitis is caused by the rubella virus, a togavirus transmitted via respiratory droplets. The virus may cross the blood-brain barrier, directly infecting neural tissues, or trigger an immune-mediated inflammatory response. This neurological involvement is a rare complication of primary rubella infection or reactivation in susceptible individuals.

Risk Factors

• Lack of prior rubella immunity or vaccination.
• Congenital rubella syndrome, where the virus is transmitted in utero.
• Immunocompromised conditions (e.g., HIV, chemotherapy) increasing susceptibility to severe disease.
• Advanced age or preexisting neurological disorders.

Symptoms

• Acute onset of fever, headache, and altered mental status.
• Seizures, confusion, or disorientation.
• Focal neurological deficits (e.g., weakness, sensory changes).
• Stiff neck or photophobia in some cases.

Diagnosis

Diagnosis involves clinical evaluation of neurological symptoms combined with laboratory confirmation of rubella infection. Cerebrospinal fluid (CSF) analysis may show pleocytosis or elevated protein. Serologic testing (IgM antibodies) or PCR for rubella virus in CSF/blood supports the diagnosis. Neuroimaging (MRI/CT) may reveal inflammatory changes.

Treatment Options

Treatment focuses on supportive care, including antipyretics, anticonvulsants for seizures, and managing intracranial pressure. Antiviral therapy is not typically used, as rubella is a self-limiting virus. Immunocompromised patients may receive immune globulin, though evidence is limited.

Prognosis and Follow-Up

Prognosis varies; mild cases may resolve with full recovery, while severe cases can lead to permanent neurological damage or death. Follow-up includes monitoring for residual deficits (e.g., cognitive impairment, motor dysfunction) and rehabilitation as needed. Long-term neurodevelopmental outcomes are assessed in pediatric cases.

Complications

• Permanent neurological sequelae (e.g., epilepsy, cognitive impairment).
• Increased intracranial pressure or cerebral edema.
• Secondary infections due to prolonged immobility.
• In congenital cases, associated systemic defects (e.g., hearing loss, cardiac anomalies).

Lifestyle & Prevention

• Vaccination with the MMR vaccine is the primary prevention strategy.
• Avoid close contact with infected individuals during outbreaks.
• Pregnant individuals should confirm immunity and avoid exposure.
• Good hygiene (e.g., handwashing) reduces transmission risk.

When to Seek Professional Help

Seek immediate care for sudden neurological symptoms (e.g., severe headache, confusion, seizures) during or after a rubella-like illness. Prompt evaluation is critical to rule out encephalitis and initiate supportive treatment.

Tips for Medical Coders

Code B06.01 is specific to rubella encephalitis. Document the presence of encephalitis (e.g., CSF findings, neuroimaging) to justify this code. Differentiate from other neurological complications of rubella (e.g., meningitis) by specifying the affected CNS structure. Ensure clinical correlation with rubella infection (confirmed via lab or exposure history).